Fiche société
CMP Development, LLC
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications3liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Spironolactone Oral SuspensionThis is a 2-part, 2 periods per part, open-label study with spironolactone oral suspension in pediatric patients with edema due to HF or hepatic cirrhosis. Both study parts will evaluate the safety, PK and PD of multiple doses of spironolactone in patients aged from birth to ≤17 years of age. | Insuffisance cardiaque | Phase 4 | À vérifier | À vérifier | |
| Spironolactone Oral SuspensionThis is a 2-part, 2 periods per part, open-label study with spironolactone oral suspension in pediatric patients with edema due to HF or hepatic cirrhosis. Both study parts will evaluate the safety, PK and PD of multiple doses of spironolactone in patients aged from birth to ≤17 years of age. | Insuffisance cardiaque | Phase 4 | À vérifier | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Spironolactone Oral Suspension | Insuffisance cardiaque | Phase 4 | NCT06021860 | A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients | NOT_YET_RECRUITING |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Spironolactone Oral Suspension | Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives. | Vascular health and risk management | ||
| Spironolactone Oral Suspension | Evaluating dosing accuracy and galenic dispersion quality in Hospital-Based pediatric spironolactone oral suspension. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | ||
| Spironolactone Oral Suspension | Optimization and stability evaluation of a pediatric spironolactone oral suspension: Formulation development and analytical validation. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V |